Antengene Entered into a Commercialization Agreement with Hansoh Pharma for Xpovio (selinexor) in the Mainland of China
August 11, 2023
Antengene Reports the First Patient Dosing in the P-I Trial (ERASER) of ATG-017 + Nivolumab for the Treatment of Advanced Solid Tu...
July 18, 2023
Antengene Receives the US FDA’s IND Clearance of ATG-031 for Advanced Solid Tumors or B-Cell Non-Hodgkin's Lymphoma
May 18, 2023
Antengene Entered into a Clinical Collaboration with MSD to Evaluate ATG-037 + Keytruda (pembrolizumab) for Solid Tumors
December 27, 2022
Antengene Reports P-I/II (TORCH-2) Study Results of ATG-008 for the Treatment of Relapsed/Metastatic Cervical Cancer
November 16, 2022
Antengene Receives the US FDA’s IND Clearance of ATG-017 to Initiate P-I (ERASER) Trial for Advanced Solid Tumors
November 1, 2022
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.